News & Trends

• 052025-09

  Salubris' Small Molecule Drug SAL0139 Clinical Trial Application Accepted for Hyperlipidemia Treatment

• 172025-07

  Breaking News! Base Editing Therapy YOLT-101 Clinical Trial Approved for Familial Hypercholesterolemia

• 042025-06

  Breaking News! China’s First ARB + Thiazide-like Diuretic Combo Hypertension Drug — Fu Li An® Approved for Market!

• 282025-05

  Salubris Obtains Exclusive License for Small Interfering RNA Drug "GW906"

• 272025-05

  Blockbuster! China's First Domestically Developed ARNI Hypertension Drug Xin Chao Tuo (Sacubitril Alisartan Calcium Tablets) Approved for Market

• 302025-04

  Salubris' Novel Hypertension Drug SAL0140 Gained Clinical Trial Approval